N1VO34:BVMF
Novo Nordisk
30,33 R$
0,00%
(0,00) 1D
11. 8., 21:31:44 GMT-3 · BRL
search
Všechny symboly
1D
5D
1M
6M
YTD
1R
5R
MAX
| Symbol | Cena | Změna | Změna (%) |
|---|
insights_autoGenerování hlavních statistik pro N1VO34…
Otevřít
30,39 R$
Max.
30,59 R$
Min.
30,21 R$
Trž. kap.
158,59 mld.
Prům. obj.
26,43 tis.
Objem
0,00
52týd. max.
42,43 R$
52týd. min.
22,90 R$
Akcie v oběhu
3,39 mld.
Počet zaměstnanců
67 tis.
Otevřít
30,39 R$
Max.
30,59 R$
Min.
30,21 R$
Trž. kap.
158,59 mld.
Prům. obj.
26,43 tis.
Objem
0,00
52týd. max.
42,43 R$
52týd. min.
22,90 R$
Akcie v oběhu
3,39 mld.
Počet zaměstnanců
67 tis.
Zpravodajské články
Ze zdrojů na internetu
www.top1markets.com
·
před 12 hodinami
Novo Nordisk Stock Fell on a Beat-and-Raise: Here's What the Market Is Really Pricing
Yahoo Finance
·
před 16 hodinami
Eli Lilly and Company (LLY) vs. Novo Nordisk A/S (NVO): Is Lilly Pulling Ahead in the $100 Billion Obesity Market?
MarketBeat
·
před 16 hodinami
Erste Group Bank Has Positive Outlook of NVO FY2026 Earnings
TradingView
·
před 1 dnem
Septerna Q2 revenue beats analyst estimates, driven by Novo Nordisk partnership
Profil
Novo Nordisk A/S is a Danish multinational pharmaceutical company headquartered in Bagsværd. Novo Nordisk is controlled by majority shareholder Novo Holdings A/S which holds approximately 28.1% of its shares and a majority of its voting shares.
Novo Nordisk manufactures and markets pharmaceutical products and services, specifically diabetes and obesity medications and devices.
Novo Nordisk employs more than 48,000 people globally, and markets its products in 168 countries. The corporation was created in 1989, through a merger of two Danish companies, which date back to the 1920s. Novo Nordisk is a full member of the European Federation of Pharmaceutical Industries and Associations.
The company was ranked 25th among Fortune's 100 Best Companies to Work For in 2010, and subsequently ranked 72nd in 2014 and 73rd in 2017. In January 2012, Novo Nordisk was named the most sustainable company in the world by the business magazine Corporate Knights, while spin-off company Novozymes was named fourth. It is a leader in the FTSE4Good Index, and the only European company in the top ten. Novo Nordisk is the largest pharmaceutical company in Denmark. Wikipedia
Informace o Novo Nordisk
Generální ředitelMaziar Mike Doustdar
Zaměstnanci66,7 tis.
Založeno21. 12. 1923
ÚstředíBagsværd, Hovedstaden, Dánsko
Odvětví-
Obsah od AI může obsahovat chyby. Další informace